Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-02 4:05 pm Unchanged | 2025-05-29 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 49,826,805 71.000% | 0 (Unchanged) | Filing History |
| 2025-03-04 5:20 pm Purchase | 2024-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,523,511 8.600% | 258,547 (+4.13%) | Filing History |
| 2024-09-03 4:15 pm Purchase | 2024-09-03 | 13D | Ultralife Corporation ULBI | WHITMORE BRADFORD T | 6,197,741 37.300% | 659,668 (+11.91%) | Filing History |
| 2024-09-03 4:11 pm Unchanged | 2024-09-03 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 49,826,805 71.300% | 0 (Unchanged) | Filing History |
| 2024-06-26 4:50 pm Unchanged | 2024-06-25 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 49,826,805 71.300% | 0 (Unchanged) | Filing History |
| 2024-03-05 4:11 pm Purchase | 2024-03-01 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 49,826,805 71.500% | 15,000,000 (+43.07%) | Filing History |
| 2024-02-12 5:07 pm Purchase | 2024-02-08 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 34,826,805 63.700% | 3,818,527 (+12.31%) | Filing History |
| 2023-11-16 09:03 am Purchase | 2023-11-13 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 31,008,278 62.400% | 730,124 (+2.41%) | Filing History |
| 2023-11-01 4:04 pm Purchase | 2023-10-27 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,264,964 10.100% | 247,112 (+4.11%) | Filing History |
| 2023-01-04 12:06 pm Purchase | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,017,852 9.900% | 139,655 (+2.38%) | Filing History |
| 2022-01-24 4:03 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 5,878,197 9.900% | -486,989 (-7.65%) | Filing History |
| 2021-12-23 4:01 pm Purchase | 2021-12-21 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 30,278,154 62.100% | 95,555 (+0.32%) | Filing History |
| 2021-01-07 11:10 am Purchase | 2021-01-06 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,365,186 11.100% | 929,845 (+17.11%) | Filing History |
| 2020-11-06 2:38 pm Purchase | 2020-10-29 | 13D | Ultralife Corporation ULBI | WHITMORE BRADFORD T | 5,538,073 34.800% | 395,347 (+7.69%) | Filing History |
| 2020-11-06 2:21 pm Unchanged | 2020-10-29 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 30,182,599 62.700% | 0 (Unchanged) | Filing History |
| 2020-10-01 4:47 pm Unchanged | 2020-09-29 | 13D | Solesence, Inc. Common Stock SLSN | WHITMORE BRADFORD T | 30,182,599 62.700% | 0 (Unchanged) | Filing History |